These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 26247112

  • 1. A NOVEL DOUBLE MUTATION VAL648ILE AND VAL804LEU OF RET PROTO-ONCOGENE IN MULTIPLE ENDOCRINE NEOPLASIA TYPE 2.
    Verrienti A, Carbone A, Bellitti P, Fabiano MC, De Rose RF, Maranghi M, Lucia P, Durante C, Rosignolo F, Pecce V, Sponziello M, Puppin C, Costante G, Bruno R.
    Endocr Pract; 2015 Nov; 21(11):1248-54. PubMed ID: 26247112
    [Abstract] [Full Text] [Related]

  • 2. A Homozygous RET K666N Genotype With an MEN2A Phenotype.
    Jaber T, Hyde SM, Cote GJ, Grubbs EG, Giles WH, Stevens CA, Dadu R.
    J Clin Endocrinol Metab; 2018 Apr 01; 103(4):1269-1272. PubMed ID: 29408964
    [Abstract] [Full Text] [Related]

  • 3. A novel Val648Ile substitution in RET protooncogene observed in a Cys634Arg multiple endocrine neoplasia type 2A kindred presenting with an adrenocorticotropin-producing pheochromocytoma.
    Nunes AB, Ezabella MC, Pereira AC, Krieger JE, Toledo SP.
    J Clin Endocrinol Metab; 2002 Dec 01; 87(12):5658-61. PubMed ID: 12466368
    [Abstract] [Full Text] [Related]

  • 4. Multiple endocrine neoplasia type 2A due to an exon 8 (G533C) mutation in a large North American kindred.
    Castro MR, Thomas BC, Richards ML, Zhang J, Morris JC.
    Thyroid; 2013 Dec 01; 23(12):1547-52. PubMed ID: 23461807
    [Abstract] [Full Text] [Related]

  • 5. A rare missense variant in RET exon 8 in a Portuguese family with atypical multiple endocrine neoplasia type 2A.
    Martins AF, Martins JM, do Vale S, Dias T, Silveira C, da Silva IR, Carmo-Fonseca M.
    Hormones (Athens); 2016 Jul 01; 15(3):435-440. PubMed ID: 27838608
    [Abstract] [Full Text] [Related]

  • 6. Clinical Features of a Family with Multiple Endocrine Neoplasia Type 2A Caused by the D631Y RET Mutation.
    Ospina NS, Maraka S, Donegan D, Morris JC.
    Thyroid; 2017 Oct 01; 27(10):1332-1334. PubMed ID: 28747092
    [Abstract] [Full Text] [Related]

  • 7. Multiple endocrine neoplasia type 2A. Study of a family.
    Correia MJ, Lopes LO, Bugalho MJ, Cristina L, Santos AI, Bordalo AD, Pinho B, da Silva HL, Gonçalves MD, Ribeiro C, Tuna JL.
    Rev Port Cardiol; 2000 Jan 01; 19(1):11-31. PubMed ID: 10731788
    [Abstract] [Full Text] [Related]

  • 8. The RET p.G533C mutation confers predisposition to multiple endocrine neoplasia type 2A in a Brazilian kindred and is able to induce a malignant phenotype in vitro and in vivo.
    Oliveira MN, Hemerly JP, Bastos AU, Tamanaha R, Latini FR, Camacho CP, Impellizzeri A, Maciel RM, Cerutti JM.
    Thyroid; 2011 Sep 01; 21(9):975-85. PubMed ID: 21834681
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Rudolf-Virchow-Preis 1995. The role of RET proto-oncogene mutation analysis in the diagnosis of multiple endocrine neoplasia type 2 (MEN 2) gene carriers and in the discrimination of sporadic and familial medullary thyroid carcinomas and pheochromocytomas.
    Komminoth P.
    Verh Dtsch Ges Pathol; 1995 Sep 01; 79():L-LV. PubMed ID: 8600671
    [Abstract] [Full Text] [Related]

  • 11. Nationwide French Study of RET Variants Detected from 2003 to 2013 Suggests a Possible Influence of Polymorphisms as Modifiers.
    Lebeault M, Pinson S, Guillaud-Bataille M, Gimenez-Roqueplo AP, Carrie A, Barbu V, Pigny P, Bezieau S, Rey JM, Delvincourt C, Giraud S, Veyrat-Durebex C, Saulnier P, Bouzamondo N, Chabbert M, Blin J, Mohamed A, Romanet P, Borson-Chazot F, Rohmer V, Barlier A, Mirebeau-Prunier D.
    Thyroid; 2017 Dec 01; 27(12):1511-1522. PubMed ID: 28946813
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. RET germline mutations identified by exome sequencing in a Chinese multiple endocrine neoplasia type 2A/familial medullary thyroid carcinoma family.
    Qi XP, Ma JM, Du ZF, Ying RB, Fei J, Jin HY, Han JS, Wang JQ, Chen XL, Chen CY, Liu WT, Lu JJ, Zhang JG, Zhang XN.
    PLoS One; 2011 Dec 01; 6(5):e20353. PubMed ID: 21655256
    [Abstract] [Full Text] [Related]

  • 14. [A comparison of clinical characteristics between 2 pedigrees of multiple endocrine neoplasia type 2A with different RET mutations].
    Weng Y, Xue SN, Zhang SL, Cheng H, Yan L.
    Zhonghua Nei Ke Za Zhi; 2018 Feb 01; 57(2):134-137. PubMed ID: 29397600
    [Abstract] [Full Text] [Related]

  • 15. A 6-Base Pair in Frame Germline Deletion in Exon 7 Of RET Leads to Increased RET Phosphorylation, ERK Activation, and MEN2A.
    Latteyer S, Klein-Hitpass L, Khandanpour C, Zwanziger D, Poeppel TD, Schmid KW, Führer D, Moeller LC.
    J Clin Endocrinol Metab; 2016 Mar 01; 101(3):1016-22. PubMed ID: 26765577
    [Abstract] [Full Text] [Related]

  • 16. Spectrum of Germline RET variants identified by targeted sequencing and associated Multiple Endocrine Neoplasia type 2 susceptibility in China.
    Qi XP, Zhao JQ, Fang XD, Lian BJ, Li F, Wang HH, Cao ZL, Zheng WH, Cao J, Chen Y.
    BMC Cancer; 2021 Apr 07; 21(1):369. PubMed ID: 33827484
    [Abstract] [Full Text] [Related]

  • 17. A newly detected mutation of the RET protooncogene in exon 8 as a cause of multiple endocrine neoplasia type 2A.
    Bethanis S, Koutsodontis G, Palouka T, Avgoustis C, Yannoukakos D, Bei T, Papadopoulos S, Linos D, Tsagarakis S.
    Hormones (Athens); 2007 Apr 07; 6(2):152-6. PubMed ID: 17704047
    [Abstract] [Full Text] [Related]

  • 18. High penetrance of pheochromocytoma in multiple endocrine neoplasia 2 caused by germ line RET codon 634 mutation in Japanese patients.
    Imai T, Uchino S, Okamoto T, Suzuki S, Kosugi S, Kikumori T, Sakurai A, MEN Consortium of Japan.
    Eur J Endocrinol; 2013 May 07; 168(5):683-7. PubMed ID: 23416954
    [Abstract] [Full Text] [Related]

  • 19. Patients with RET D631Y mutations most commonly present with pheochromocytoma and not medullary thyroid carcinoma.
    Elston MS, Meyer-Rochow GY, Holdaway I, Conaglen JV.
    Horm Metab Res; 2012 May 07; 44(5):339-42. PubMed ID: 22274720
    [Abstract] [Full Text] [Related]

  • 20. RET proto-oncogene mutations are restricted to codons 634 and 918 in mainland Chinese families with MEN2A and MEN2B.
    Zhou Y, Zhao Y, Cui B, Gu L, Zhu S, Li J, Liu J, Yin M, Zhao T, Yin Z, Yu C, Chen C, Wang L, Xiao B, Hong J, Zhang Y, Tang Z, Wang S, Li X, Ning G.
    Clin Endocrinol (Oxf); 2007 Oct 07; 67(4):570-6. PubMed ID: 17573899
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.